Stanford researchers have developed an AI-powered "virtual scientist" capable of designing drug and vaccine candidates, marking a leap forward in biomedical research.
Open Access Government investigates the strides being made by Executive Vice-President for the European Green Deal Frans Timmermans and the Commission to work towards the Green Deal’s ambitious goals during COVID-19.
Defence and Security Experts Nick Newman and Chris Cole of global innovation and transformation consultancy PA Consulting, discuss how online safety has taken a hit amidst the COVID-19 pandemic and how to work together to end the sexual exploitation of children online.
Social Value Portal discusses how rethinking social value priorities to reflect the current and future challenges of COVID-19 is crucial for sustainable social value.
In this final article of a series of five, Oxford Cannabinoid Technologies will discuss their expertise on the use of cannabinoids in medicine when it comes to treating COVID-19.
Genevieve Leveille, CEO of UK firm 08 Group and Co-Chair of the TechUK DLT Working Group, collaborates with digital health tech companies to deliver verified-safe China-sourced Covid-19 test kits at scale.
Michal Skwierczyński, Coordinator of the BioMotive project, explores the benefits of bio-based solutions for both automotive and wider industries post COVID-19.
Here, experts Stephan Pleschka, Oliver Planz and Stephan Ludwig walk us through the constant threat of influenza virus outbreaks and the benefit of enduring research in antiviral drug development.
Here, Trickle Data Insights Limited offers solutions of how to support and boost your workers wellbeing and help your business thrive during a pandemic.
David Brudö, CEO of digital platform Remente, explains how COVID-19 has accelerated the need for technology to proactively address the mental health crisis.
Edgar A Whitley, Professor at LSE, co-chair of PCAG and consultant on Ada Lovelace review, highlights the problems with digital immunity certificates and contact tracing apps.
